NASDAQ:SSRX - 3SBio Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$16.59 0.00 (0.00 %)
(As of 10/21/2018 01:13 PM ET)
Previous Close$16.59
Today's RangeN/A
52-Week Range$10.15 - $16.70
Average Volume149,084 shs
Market Capitalization$366.10 million
P/E RatioN/A
Dividend YieldN/A
3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.

Receive SSRX News and Ratings via Email

Sign-up to receive the latest news and ratings for SSRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A
Market Cap$366.10 million

3SBio (NASDAQ:SSRX) Frequently Asked Questions

What is 3SBio's stock symbol?

3SBio trades on the NASDAQ under the ticker symbol "SSRX."

How were 3SBio's earnings last quarter?

3SBio Inc (NASDAQ:SSRX) released its quarterly earnings results on Monday, March, 18th. The biotechnology company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.14 by $0.02. The biotechnology company earned $26.30 million during the quarter, compared to analyst estimates of $25.63 million. View 3SBio's Earnings History.

Who are 3SBio's key executives?

3SBio's management team includes the folowing people:
  • Jing Lou, Executive Chairman of the Board, Chief Executive Officer (Age 54)
  • Bo Tan, Chief Financial Officer, Executive Vice President, Executive Director (Age 44)
  • Fei You, Director - Finance (Age 38)
  • Weihonghas Xiao, Chief Operating Officer (Age 48)
  • Dongmei Su, Senior Vice President, Executive Director (Age 46)
  • Zhenping Zhu MD. Ph.D., Chief Scientific Officer, President - Research & Development (Age 52)
  • Bin Huang, Vice President, Executive Director (Age 56)
  • Xin Ma, Vice President - Human Resources (Age 51)
  • Yongfu Chen, Vice President (Age 60)
  • Kevin Liu, Vice President (Age 47)

How do I buy shares of 3SBio?

Shares of SSRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 3SBio's stock price today?

One share of SSRX stock can currently be purchased for approximately $16.59.

How big of a company is 3SBio?

3SBio has a market capitalization of $366.10 million.

What is 3SBio's official website?

The official website for 3SBio is

How can I contact 3SBio?

3SBio's mailing address is No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone, SHENYANG, LIA 110027, China. The biotechnology company can be reached via phone at +86-24-25811820.

MarketBeat Community Rating for 3SBio (NASDAQ SSRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  177
MarketBeat's community ratings are surveys of what our community members think about 3SBio and other stocks. Vote "Outperform" if you believe SSRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel